Evidence map›Paper›PMID 28138241›Full record

ArticleInternational journal of nanomedicine2017

Nanoengineered implant as a new platform for regenerative nanomedicine using 3D well-organized human cell spheroids.

Laetitia Keller, Ysia Idoux-Gillet, Quentin Wagner, Sandy Eap, David Brasse, Pascale Schwinté, Manuel Arruebo, Nadia Benkirane-Jessel

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Laetitia KellerINSERM (French National Institute of Health and Medical Research), "Osteoarticular and Dental Regenerative Nanomedicine" Laboratory, UMR 1109, Faculté de Médecine, FMTS; University of Strasbourg, Faculté de Chirurgie Dentaire.
Ysia Idoux-GilletINSERM (French National Institute of Health and Medical Research), "Osteoarticular and Dental Regenerative Nanomedicine" Laboratory, UMR 1109, Faculté de Médecine, FMTS; University of Strasbourg, Faculté de Chirurgie Dentaire.
Quentin WagnerINSERM (French National Institute of Health and Medical Research), "Osteoarticular and Dental Regenerative Nanomedicine" Laboratory, UMR 1109, Faculté de Médecine, FMTS; University of Strasbourg, Faculté de Chirurgie Dentaire.
Sandy EapINSERM (French National Institute of Health and Medical Research), "Osteoarticular and Dental Regenerative Nanomedicine" Laboratory, UMR 1109, Faculté de Médecine, FMTS; University of Strasbourg, Faculté de Chirurgie Dentaire.
David BrasseCNRS (Centre National de la Recherche Scientifique), UMR 7178, IPHC (Hubert Curien Multidisciplinary Institute), Strasbourg, France.
Pascale SchwintéINSERM (French National Institute of Health and Medical Research), "Osteoarticular and Dental Regenerative Nanomedicine" Laboratory, UMR 1109, Faculté de Médecine, FMTS; University of Strasbourg, Faculté de Chirurgie Dentaire.
Manuel ArrueboDepartment of Chemical Engineering, INA (Aragon Nanoscience Institute), University of Zaragoza, Zaragoza, Spain.
Nadia Benkirane-JesselINSERM (French National Institute of Health and Medical Research), "Osteoarticular and Dental Regenerative Nanomedicine" Laboratory, UMR 1109, Faculté de Médecine, FMTS; University of Strasbourg, Faculté de Chirurgie Dentaire.
Regenerative NanoMedicine · FRImmuno-Rhumathologie moléculaireInstitut Pluridisciplinaire Hubert Curien · FRUniversidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In tissue engineering, it is still rare today to see clinically transferable strategies for tissue-engineered graft production that conclusively offer better tissue regeneration than the already existing technologies, decreased recovery times, and less risk of complications. Here a novel tissue-engineering concept is presented for the production of living bone implants combining 1) a nanofibrous and microporous implant as cell colonization matrix and 2) 3D bone cell spheroids. This combination, double 3D implants, shows clinical relevant thicknesses for the treatment of an early stage of bone lesions before the need of bone substitutes. The strategy presented here shows a complete closure of a defect in nude mice calvaria after only 31 days. As a novel strategy for bone regenerative nanomedicine, it holds great promises to enhance the therapeutic efficacy of living bone implants.

Indexed as

Prostheses and ImplantsAnimalsBone RegenerationCalcification, PhysiologicCell Culture TechniquesHumansMice, NudeNanomedicineNanoparticlesNanotechnologyOsteoblastsPolymersPorosityRegenerative MedicineSpheroids, CellularTissue EngineeringPolymersbioengineeringimplantsmatrix mineralizationmicrotissuesosteoblasts

Identifiers

PMID28138241
PMCPMC5238755
OpenAlexW2579866418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.